We are live on ! Find out more
FO

FT Options Portfolio holdings

AUM $66.4M
1-Year Est. Return 18.48%
This Fund
S&P 500
This Quarter Est. Return
+11.45%
1 Year Est. Return
+18.48%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$76M
AUM Growth
-$11.1M
Cap. Flow
+$112M
Cap. Flow %
147.28%
Top 10 Hldgs %
38.02%
Holding
408
New
159
Increased
53
Reduced
54
Closed
131

Top Buys

Rank Stock Value
1
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
+$3.17M
2
K
Kellanova
K
+$2.19M
3
FL
Foot Locker
FL
+$2.04M
4
GIS icon
General Mills
GIS
+$1.95M
5
LULU icon
lululemon athletica
LULU
+$1.74M

Top Sells

Rank Stock Value
1
REGN icon
Regeneron Pharmaceuticals
REGN
+$9.7M
2
JPM icon
JPMorgan Chase
JPM
+$3.58M
3
GILD icon
Gilead Sciences
GILD
+$3.38M
4
STZ icon
Constellation Brands
STZ
+$2.74M
5
ALXN
Alexion Pharmaceuticals
ALXN
+$2M

Sector Composition

Rank Sector Weight
1 Healthcare 34.66%
2 Consumer Staples 16.16%
3 Consumer Discretionary 9.31%
4 Communication Services 3.38%
5 Materials 2.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
B
251
CALL
Barrick Mining
B
$62.9B
$4K 0.01%
+13,700
New +$253K
IBB icon
252
CALL
iShares Biotechnology ETF
IBB
$9.32B
$4K 0.01%
+15,000
New +$1.44M
INFY icon
253
PUT
Infosys
INFY
$44B
$4K 0.01%
39,200
-81,000
-67% -$604K
NKTR icon
254
PUT
Nektar Therapeutics
NKTR
$2.35B
$4K 0.01%
+2,333
New +$524K
UL icon
255
PUT
Unilever
UL
$133B
$4K 0.01%
+4,444
New +$225K
XBI icon
256
CALL
State Street SPDR S&P Biotech ETF
XBI
$10.3B
$4K 0.01%
+30,000
New +$2.01M
OCLR
257
PUT
DELISTED
Oclaro Inc.
OCLR
$4K 0.01%
+6,600
New +$62K
ACM icon
258
CALL
Aecom
ACM
$8.71B
$3K ﹤0.01%
+14,300
New +$523K
BHC icon
259
CALL
Bausch Health
BHC
$1.71B
$3K ﹤0.01%
30,000
+7,500
+33% +$103K
BHC icon
260
PUT
Bausch Health
BHC
$1.71B
$3K ﹤0.01%
20,000
-25,000
-56% -$344K
GDX icon
261
PUT
VanEck Gold Miners ETF
GDX
$23.6B
$3K ﹤0.01%
+10,000
New +$233K
OTIC
262
CALL
DELISTED
Otonomy, Inc.
OTIC
$3K ﹤0.01%
+1,700
New +$24.8K
MON
263
PUT
DELISTED
Monsanto Co
MON
$3K ﹤0.01%
5,100
+1,100
+28% +$122K
ADSK icon
264
PUT
Autodesk
ADSK
$43.2B
$2K ﹤0.01%
+4,000
New +$335K
CTSH icon
265
PUT
Cognizant
CTSH
$20.6B
$2K ﹤0.01%
4,600
-10,400
-69% -$598K
PPC icon
266
PUT
Pilgrim's Pride
PPC
$6.81B
$2K ﹤0.01%
+20,500
New +$415K
SIOX
267
PUT
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$2K ﹤0.01%
+263
New +$27.6K
CNCE
268
CALL
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
$2K ﹤0.01%
+10,000
New +$120K
XLNX
269
CALL
DELISTED
Xilinx Inc
XLNX
$2K ﹤0.01%
12,500
-25,500
-67% -$1.5M
EBIX
270
CALL
DELISTED
Ebix Inc
EBIX
$2K ﹤0.01%
+1,300
New +$77.2K
CCEP icon
271
PUT
Coca-Cola Europacific Partners
CCEP
$46.9B
$1K ﹤0.01%
400
– –
CSCO icon
272
CALL
Cisco
CSCO
$445B
$1K ﹤0.01%
+20,000
New +$649K
NVDA icon
273
PUT
NVIDIA
NVDA
$5.17T
$1K ﹤0.01%
+80,000
New +$213K
PLCE icon
274
CALL
Children's Place
PLCE
$59.4M
$1K ﹤0.01%
+5,000
New +$527K
VEEV icon
275
PUT
Veeva Systems
VEEV
$29.9B
$1K ﹤0.01%
12,300
+2,300
+23% +$103K
9 10
11
12 13

Similar funds

MC
Micawber Capital Seattle, Washington $62.9M AUM 20.32% 1-Year Est. Return
FIM
Friedberg Investment Management Houston, Texas $61.9M AUM 20.07% 1-Year Est. Return
TLIC
Thai Life Insurance Company Bangkok, Thailand $71M AUM 20.14% 1-Year Est. Return
MKCM
Mount Kellett Capital Management New York $61M AUM 12.22% 1-Year Est. Return
ACM
Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return
MFM
Marianas Fund Management New York $58.1M AUM 10.84% 1-Year Est. Return
VE
Vega Energy New York $75.5M AUM 15.36% 1-Year Est. Return
GFWEV
G.F.W. Energy VIII Irving, Texas $76.3M AUM 11.41% 1-Year Est. Return

FT Options's Q1 2017 Portfolio in Review

As of Q1 2017, FT Options held 408 positions worth $76M, down 13% from $87.1M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

FT Options deployed $112M of net new capital in Q1 2017, opening 159 new positions and adding to 53 existing holdings. Its largest new stake was GW Pharmaceuticals Plc American Depositary Shares: 25,829 shares worth $3.12M.

By sector, the portfolio is most concentrated in Healthcare at 35% of assets, down from 45% a quarter earlier, followed by Consumer Staples and Consumer Discretionary.

On the sell side, the largest reduction was Regeneron Pharmaceuticals, an estimated $9.7M trimmed.

  • FT Options's largest Q1 2017 buy was GW Pharmaceuticals Plc American Depositary Shares: 25,829 shares worth $3.12M.
  • FT Options added most to Kellanova in Q1 2017, an estimated $2.19M increase.
  • FT Options's biggest Q1 2017 reduction was Regeneron Pharmaceuticals, cutting an estimated $9.7M.
  • FT Options fully exited JPMorgan Chase in Q1 2017, selling an estimated $3.58M.
  • FT Options's ten largest holdings make up 38% of its $76M portfolio in Q1 2017.
  • FT Options opened 159 new positions and closed 131 in Q1 2017.
  • FT Options's portfolio value fell 13% quarter-over-quarter to $76M.

Based on FT Options's 13F filing for Q1 2017, filed 12 May 2017.